SCHEMBL2368567

SCHEMBL2368567

Clc1ccc(-c2csc3ncnc(NCCc4ccccc4)c23)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
HTT P42858 3/20 0.61
MAPT P10636 3/20 0.61
KDM4E B2RXH2 2/20 0.61
ALDH1A1 P00352 3/20 0.60
ESR1 P03372 1/20 0.55
FGFR1 P11362 2/20 0.55
TNF P01375 1/20 0.55
MAPK1 P28482 1/20 0.55
NOD1 Q9Y239 1/20 0.55
NCOA1 Q15788 1/20 0.54
NCOA3 Q9Y6Q9 1/20 0.54
KMT2A Q03164 1/20 0.54
ATM Q13315 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
CCNC P24863 1/20 0.53
CDK8 P49336 1/20 0.53
CSNK2A2 P19784 1/20 0.53
CSNK2B P67870 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1902694 0.95 ESR1 (0.61) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2369595 0.92 MAPK1 (0.63) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2369016 0.89 ATM (0.68) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2369138 0.84 ALDH1A1 (0.61) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2369091 0.81 SMN1; SMN2 (0.64) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2369277 0.79 CCNC (0.78) LMNASMN1; SMN2HTTKDM4EALDH1A1
SCHEMBL2369218 0.79 SMN1; SMN2 (0.58) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2369554 0.79 ALDH1A1 (0.57) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL3338189 0.79 HTT (0.62) LMNASMN1; SMN2HTTMAPTKDM4E
SCHEMBL2368569 0.79 TNF (0.83) LMNASMN1; SMN2HTTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022076-B2 Thieno[2,3-d]pyrimidine derivatives as potassium channel modulators; antiarrhythmia agents XENTION LIMITED (GB) 2011-09-20 US disclosed
EP-1641803-B3 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2010-12-08 EP disclosed
EP-1641803-B1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2009-03-18 EP disclosed
EP-1641803-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS Xention Discovery Limited (GB) 2006-04-05 EP disclosed
WO-2004111057-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION DISCOVERY LIMITED (GB) 2004-12-23 WO disclosed